The DVSMCs were incubated with IL-17, IL-17 neutralizing antibody, SSc serum, SSc serum, and IL-17 neutralizing antibody, tanshinone IIA, IL-17, and tanshinone IIA, and SSc serum and tanshinone IIA for 3 days. The gene discussed is IL17A; the disease is systemic sclerosis.